Core Insights - The Royce Small-Cap Trust is a closed-end diversified management investment company focused on long-term capital growth by investing primarily in small-cap and micro-cap companies [10][8] - As of June 30, 2025, the Fund's net asset value (NAV) is $16.74, while the market price (MKT) is $15.05, indicating a potential discount for investors [1] - The Fund's average annual total return for the one-year period is 10.37% for NAV and 13.43% for MKT, showing strong performance relative to the market [1] Performance Metrics - The Fund's average annual total return as of June 30, 2025, includes: - One-Month: NAV 4.56%, MKT 3.31% - Year to Date: NAV 2.57%, MKT -0.84% - Three-Year: NAV 13.54%, MKT 11.33% - Five-Year: NAV 12.18%, MKT 12.78% - Ten-Year: NAV 9.46%, MKT 9.82% [1] - The Fund's net assets total $2.00 billion, with an average market capitalization of $3.06 billion [4] Portfolio Composition - The top ten positions in the Fund account for the following percentages of net assets: - IES Holdings: 1.8% - Assured Guaranty: 1.5% - SEI Investments: 1.4% - Other notable positions include PAR Technology, E-L Financial, and APi Group, each contributing between 1.0% and 1.3% [7][9] - The Fund's sector allocation is as follows: - Industrials: 24.4% - Financials: 23.3% - Information Technology: 14.5% - Health Care: 9.9% - Consumer Discretionary: 9.6% [10] Investment Strategy - The Fund aims to invest at least 65% of its assets in equity securities of small- and micro-cap companies, which may involve higher risks compared to larger-cap investments [10][3] - The Fund's investment adviser has over 50 years of experience in small- and micro-cap investments, indicating a strong expertise in this niche market [8]

Core Insights - Value investing provides an opportunity to acquire overlooked stocks that are trading at low multiples, particularly using the price-to-book (P/B) ratio as a metric for identifying potential bargains with high-growth prospects [1][2] Understanding P/B Ratio - The P/B ratio is calculated as market capitalization divided by book value of equity, helping to identify low-priced stocks with high growth potential [2] - A P/B ratio of less than one indicates that a stock is undervalued, while a ratio greater than one suggests it may be overvalued [5][6] - The P/B ratio is particularly relevant for industries with tangible assets, such as finance and manufacturing, but may be misleading for companies with high R&D expenditures or significant debt [8] Screening Parameters - Stocks were screened based on several criteria, including a P/B ratio less than the industry median, a P/S ratio lower than the industry average, and a PEG ratio of less than 1, indicating undervaluation relative to growth prospects [11][12][13] - Additional criteria included a minimum current price of $5, an average 20-day trading volume of at least 100,000, and a Zacks Rank of 1 or 2, which indicates strong buy potential [14] Selected Stocks - Five stocks identified with low P/B ratios and strong projected EPS growth include: - **USANA Health Sciences (USNA)**: Projected 3-5 year EPS growth rate of 12.0%, Zacks Rank 2, Value Score A [15] - **CVS Health (CVS)**: Projected 3-5 year EPS growth rate of 11.4%, Zacks Rank 2, Value Score A [16] - **Pfizer (PFE)**: Projected 3-5 year EPS growth rate of 9.0%, Zacks Rank 2, Value Score A [17] - **StoneCo (STNE)**: Highest projected 3-5 year EPS growth rate at 26.3%, Zacks Rank 1, Value Score B [10][18] - **Paysafe Limited (PSFE)**: Projected 3-5 year EPS growth rate of 17.9%, Zacks Rank 2, Value Score A [19]